Literature DB >> 15468044

Introduction. Advances in Gaucher Disease: therapeutic goals and evaluation and monitoring guidelines.

Neal J Weinreb1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15468044     DOI： 10.1053/j.seminhematol.2004.07.008

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  4 in total

1.  Unexpected macrophage-independent dyserythropoiesis in Gaucher disease.

Authors:  Nelly Reihani; Jean-Benoit Arlet; Michael Dussiot; Thierry Billette de Villemeur; Nadia Belmatoug; Christian Rose; Yves Colin-Aronovicz; Olivier Hermine; Caroline Le Van Kim; Melanie Franco
Journal:  Haematologica       Date:  2016-07-28       Impact factor: 9.941

2.  Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients.

Authors:  A El-Beshlawy; L Ragab; I Youssry; K Yakout; H El-Kiki; K Eid; I M Mansour; S Abd El-Hamid; M Yang; P K Mistry
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

3.  Review of the safety and efficacy of imiglucerase treatment of Gaucher disease.

Authors:  Deborah Elstein; Ari Zimran
Journal:  Biologics       Date:  2009-09-15

4.  Achievement of therapeutic goals with low-dose imiglucerase in Gaucher disease: a single-center experience.

Authors:  Irina Tukan; Irith Hadas-Halpern; Gheona Altarescu; Ayala Abrahamov; Deborah Elstein; Ari Zimran
Journal:  Adv Hematol       Date:  2013-10-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.